輕度和中度乙型(β)地中海貧血
支持性療法
排鐵劑(鐵螯合劑)
Iron out for nontransfused thalassemia. (開啟新視窗)
出處: Blood 2012;120(5):928-9.
檢索: PubMed 22859709
DOI碼: 10.1182/blood-2012-06-433227
Iron overload in β-thalassemia intermedia: an emerging concern. (開啟新視窗)
出處: Curr Opin Hematol 2013;20(3):187-92.
檢索: PubMed 23426199
DOI碼: 10.1097/MOH.0b013e32835f5a5c
營養補給和其他支持性療法
Treatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertension. (開啟新視窗)
出處: Blood 2012;120(7):1531-2.
檢索: PubMed 22899478
DOI碼: 10.1182/blood-2012-04-422568
Prevalance of iron deficiency in thalassemia minor: a study from tertiary hospital. (開啟新視窗)
出處: Indian J Hematol Blood Transfus 2012;28(1):7-9.
檢索: PubMed 23449336
DOI碼: 10.1007/s12288-011-0088-9
Therapeutic roles of curcumin: lessons learned from clinical trials. (開啟新視窗)
出處: AAPS J 2013;15(1):195-218.
檢索: PubMed 23143785
DOI碼: 10.1208/s12248-012-9432-8
Vitamin E supplement improves erythrocyte membrane fluidity of thalassemia: an ESR spin labeling study. (開啟新視窗)
出處: J Med Assoc Thai 2012;95(1):29-36.
檢索: PubMed 22379738
Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients. (開啟新視窗)
出處: Am J Hematol 2013;88(6):503-6.
檢索: PubMed 23553596
DOI碼: 10.1002/ajh.23445